Vaccine clinical trials to treat and potentially prevent type 1 diabetes 28 April 2021 An oral vaccine that could treat or potentially prevent type 1 diabetes is in clinical trials at the University of Queensland. Associate Professor Emma Hamilton-Williams hopes the research will end the lifelong dependency on insulin. With the support of the Diabetes Australia Research Program researchers are aiming to create a vaccine that can re-educate the t-cells in the immune system to stop the pathogenic process that leads them to destroy the insulin-producing cells in the pancreas. You can watch the video here:
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 3 May 2026 Diabetes and Alzheimer’s: separating fact from fiction While research shows that type 2 diabetes is associated with a higher risk of Alzheimer's, many people with diabetes never develop dementia, and Alzheimer’s disease also affects people without diabetes. Continue Reading